Article Information
History
- January 25, 2018.
Article Versions
- You are currently viewing Version 1 of this article (January 25, 2018 - 15:57).
- Version 2 (February 16, 2018 - 10:32).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Jessica Schulz1,$,
- Petros Takousis2,$,
- Inken Wohlers3,
- Ivie O G Itua2,
- Valerija Dobricic3,
- Harald Binder4,
- Lefkos Middleton2,
- John P A Ioannidis5,
- Robert Perneczky2,6,7,8,
- Lars Bertram2,3 and
- Christina M Lill1,*
- 1Genetic and Molecular Epidemiology Group, Institute of Neurogenetics, University of Lübeck, Lübeck, Germany
- 2Neuroepidemiology and Ageing Research Unit, School of Public Health, Imperial College, London, UK
- 3Lübeck Interdisciplinary Platform for Genome Analytics (LIGA), Institutes of Neurogenetics & Integrative and Experimental Genomics, University of Lübeck, Lübeck, Germany
- 4Institute for Medical Biometry and Statistics, Faculty of Medicine and Medical Center - University of Freiburg, Germany
- 5Departments of Medicine, Health Research and Policy, Biomedical Data Science, and Statistics, and Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, California, CA 94305, USA
- 6Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-Universität München, Germany
- 7German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany
- 8West London Mental Health NHS Trust, London, UK
- ↵$joint first authors
- *Correspondence to: Christina M. Lill, MD, MSc, Genetic and Molecular Epidemiology Group, Institute of Neurogenetics, University of Lübeck, Maria-Goeppert-Str. 1, 23562 Lübeck, Germany, e-mail: christina.lill{at}uni-luebeck.de.